Dr. Kym Baker, currently serving as the General Manager of Patheon Biologics at Thermo Fisher Scientific Brisbane Biologics site, brings over 30 years of extensive experience in biomanufacturing in both Australia and the UK. Passionate about maintaining strategic competitiveness in biotechnology across Australia and the Asia-Pacific (APAC) during the fourth Industrial Revolution, Kym is dedicated to mentoring and coaching the next generation of scientists and engineers to become leaders of tomorrow. Kym's vast expertise spans research, early development, process development, and clinical and commercial manufacturing stages, having successfully taken multiple biologics products from development to commercialization at Lonza, UK, and currently at Thermo Fisher Scientific.

Dr. Denise Hodge, the Founder and CO-CEO of JourneyTech, a leading research and technology translation, and commercialization service, also joins the Life Sciences Queensland Board. Denise's strong foundation in biological sciences, coupled with her background as a registered patent attorney in Australia and New Zealand, provides critical expertise in Intellectual Property (IP) strategy and management. With extensive experience in private patent and trademark attorney firms, Denise has a proven track record in commercialization, including leadership roles at The University of Edinburgh and Agriculture Victoria, before establishing JourneyTech.

Trent Munro, Sarah Meibusch, and Sagadevan Mundree, existing members of the LSQ Board, warmly welcome Kym Baker and Denise Hodge. The Board collectively looks forward to leveraging their diverse expertise and insights to drive the Life Sciences sector forward in 2024.